Advertisement.

VNDA Projected Dividend Yield

Vanda Pharmaceuticals Inc ( NASDAQ : VNDA )

Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for high unmet medical needs. Its commercial portfolio includes HETLIOZ for non-24-hour sleep-wake disorder and sleep disturbances in Smith-Magenis syndrome, Fanapt for bipolar I disorder and schizophrenia, and PONVORY for inflammatory/autoimmune disorders like ulcerative colitis and psoriasis. The company also has several drugs in development, including Tradipitant, VHX-896, VSJ-110, VPO-227, VTR-297, VQW-765, VCA-894A, and Type 2S (CMT2S).

21 YEAR PERFORMANCE RESULTS

VNDA Dividend History Detail
VNDA Dividend News
VNDA Competitors News

# of Shares: 0

Closing Price: 4.14

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000